These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2878580)

  • 1. The dopamine D1 receptor: biochemical and behavioral aspects.
    Andersen PH; Nielsen EB
    Adv Exp Med Biol; 1986; 204():73-91. PubMed ID: 2878580
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Adv Exp Med Biol; 1986; 204():29-52. PubMed ID: 2878579
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional interactive effects of D1 and D2 dopamine receptor blockade.
    Salama AI; Saller CF
    Adv Exp Med Biol; 1986; 204():137-50. PubMed ID: 2947425
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of dopamine D-1 and D-2 receptors.
    Hyttel J; Arnt J
    Adv Exp Med Biol; 1986; 204():15-28. PubMed ID: 2878578
    [No Abstract]   [Full Text] [Related]  

  • 5. Cocaine administration: D1 dopamine receptor function and dopamine clearance/diffusion in rat striatum and nucleus accumbens.
    Zahniser NR; Mayfield RD; Cass WA; Gerhardt GA
    Ann N Y Acad Sci; 1992 Jun; 654():537-9. PubMed ID: 1385936
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia.
    Creese I; Hess EJ
    Clin Neuropharmacol; 1986; 9 Suppl 4():14-6. PubMed ID: 2882838
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
    Onali P; Olianas MC; Gessa GL
    Eur J Pharmacol; 1984 Mar; 99(1):127-8. PubMed ID: 6233165
    [No Abstract]   [Full Text] [Related]  

  • 8. Benzazepines: structure-activity relationships between D1 receptor blockade and selected pharmacological effects.
    Iorio LC; Barnett A; Billard W; Gold EH
    Adv Exp Med Biol; 1986; 204():1-14. PubMed ID: 2947422
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.
    Creese I; Chen A
    Eur J Pharmacol; 1985 Feb; 109(1):127-8. PubMed ID: 2859993
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of ceruletide on perioral movements and the dopamine receptor-adenylate cyclase system in rats chronically treated with fluphenazine.
    Ashizawa T; Saito T; Takahata N
    Psychopharmacology (Berl); 1996 Jun; 125(3):185-94. PubMed ID: 8815952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 59(3):211-6. PubMed ID: 32570
    [No Abstract]   [Full Text] [Related]  

  • 12. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep deprivation increases dopamine D1 receptor antagonist [3H]SCH 23390 binding and dopamine-stimulated adenylate cyclase in the rat limbic system.
    Demontis MG; Fadda P; Devoto P; Martellotta MC; Fratta W
    Neurosci Lett; 1990 Sep; 117(1-2):224-7. PubMed ID: 2149748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multiplicity of the D1 dopamine receptor.
    Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
    Adv Exp Med Biol; 1986; 204():53-72. PubMed ID: 2947430
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
    Lucchi L; Moresco RM; Govoni S; Trabucchi M
    Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Psychopharmacol Bull; 1986; 22(3):605-12. PubMed ID: 2879304
    [No Abstract]   [Full Text] [Related]  

  • 17. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O; De Montis G; Porceddu ML; Mele S; Calderini G; Toffano G; Biggio G
    Brain Res; 1987 Oct; 432(2):283-90. PubMed ID: 2960426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogenesis of dopamine receptor binding in the corpus striatum of the rat.
    Pardo JV; Creese I; Burt DR; Snyder SH
    Brain Res; 1977 Apr; 125(2):376-82. PubMed ID: 851885
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo binding to dopamine receptors: a correlate of potential antipsychotic activity.
    McQuade RD; Duffy RA; Coffin VL; Barnett A
    Eur J Pharmacol; 1992 Apr; 215(1):29-34. PubMed ID: 1355442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
    Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.